Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.010x

Based on the latest financial reports, Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) has a cash flow conversion efficiency ratio of 0.010x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥127.35 Million ≈ $18.63 Million USD) by net assets (CN¥12.27 Billion ≈ $1.80 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Beijing Wantai Biological Pharmacy Enter to measure how many days the company can operate on defensive assets alone.

Beijing Wantai Biological Pharmacy Enterprise Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Beijing Wantai Biological Pharmacy Enterprise Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Beijing Wantai Biological Pharmacy Enterprise Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Beijing Wantai Biological Pharmacy Enterprise Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
UNIQA Insurance Group AG VI:UQA	0.072x
AURA MINERALS INC. O.N. F:A531	0.342x
Wuxi Taclink Optoelectronics Technology Co. Ltd. A SHG:688205	N/A
Caris Life Sciences, Inc. Common Stock NASDAQ:CAI	0.055x
Budimex S.A. WAR:BDX	-0.016x
Selective Insurance Group, Inc. NASDAQ:SIGI	0.062x
Chenbro Micom Co Ltd TW:8210	0.092x
CONVATEC GRP UNSP.ADR /4 F:2CVU	N/A

Annual Cash Flow Conversion Efficiency for Beijing Wantai Biological Pharmacy Enterprise Co Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Beijing Wantai Biological Pharmacy Enterprise Co Ltd from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see 603392 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥12.03 Billion ≈ $1.76 Billion	CN¥89.75 Million ≈ $13.13 Million	0.007x	-73.85%
2024-12-31	CN¥12.45 Billion ≈ $1.82 Billion	CN¥355.08 Million ≈ $51.96 Million	0.029x	-77.09%
2023-12-31	CN¥12.88 Billion ≈ $1.89 Billion	CN¥1.60 Billion ≈ $234.72 Million	0.125x	-62.15%
2022-12-31	CN¥12.56 Billion ≈ $1.84 Billion	CN¥4.13 Billion ≈ $604.73 Million	0.329x	-10.78%
2021-12-31	CN¥4.56 Billion ≈ $667.64 Million	CN¥1.68 Billion ≈ $246.12 Million	0.369x	+103.17%
2020-12-31	CN¥2.58 Billion ≈ $377.59 Million	CN¥468.21 Million ≈ $68.51 Million	0.181x	+5.19%
2019-12-31	CN¥1.58 Billion ≈ $231.31 Million	CN¥272.68 Million ≈ $39.90 Million	0.173x	+13.49%
2018-12-31	CN¥1.37 Billion ≈ $200.54 Million	CN¥208.31 Million ≈ $30.48 Million	0.152x	-7.02%
2017-12-31	CN¥898.99 Million ≈ $131.55 Million	CN¥146.97 Million ≈ $21.51 Million	0.163x	+21.25%
2016-12-31	CN¥959.70 Million ≈ $140.43 Million	CN¥129.40 Million ≈ $18.94 Million	0.135x	-35.82%
2015-12-31	CN¥722.69 Million ≈ $105.75 Million	CN¥151.84 Million ≈ $22.22 Million	0.210x	-7.93%
2014-12-31	CN¥580.32 Million ≈ $84.92 Million	CN¥132.43 Million ≈ $19.38 Million	0.228x	-10.88%
2013-12-31	CN¥382.06 Million ≈ $55.91 Million	CN¥97.83 Million ≈ $14.32 Million	0.256x	--

About Beijing Wantai Biological Pharmacy Enterprise Co Ltd

SHG:603392 China Biotechnology

Market Cap

$5.08 Billion

CN¥34.71 Billion CNY

Market Cap Rank

#3563 Global

#538 in China

Share Price

CN¥27.45

Change (1 day)

+0.18%

52-Week Range

CN¥27.40 - CN¥62.34

All Time High

CN¥142.90